Andrew Wood
@andrewwood.bsky.social
Research Group Leader at the University of Edinburgh. Using genome editing and targeted protein degradation to study mechanisms underlying human disease and therapy.
🔬 New preprint: How does the mode of oncogene activation shape PROTAC efficacy? Led by Evelina Gudauskaite, we ask whether stabilising mutations vs transcriptional upregulation have distinct consequences for targeted protein degradation. www.biorxiv.org/content/10.6....
biorxiv.org
🔬 New preprint: How does the mode of oncogene activation shape PROTAC efficacy? Led by Evelina Gudauskaite, we ask whether stabilising mutations vs transcriptional upregulation have distinct consequences for targeted protein degradation. www.biorxiv.org/content/10.6....
biorxiv.org
Congratulations to Tom Deegan who receives the Colworth Medal in 2027! Pioneering work from the Deegan Lab has redefined our understanding of eukaryotic DNA replication and provided conceptual and technical frameworks that continue to drive new discoveries across molecular biology.
Online now! Online now! Assessing the suitability of deubiquitylases as substrates for targeted protein degradation #chembiol
Assessing the suitability of deubiquitylases as substrates for targeted protein degradation
Tong et al. describe a chemical genetic system to evaluate the degradability of deubiquitylase (DUBs) enzymes by PROTACs that do not inhibit their catalytic activity. They find that some Dubs are readily degradable, others resist degradation through auto-deubiquitylation, and some are inherently poor proteasome substrates because they are difficult to unfold.
dlvr.it
An elegant approach using a mix of technologies and making the most of resources generated over many years of research into the canonical Wnt pathway. And results which have the potential to andvance personalised treatment for some forms of cancer. Congrats @andrewwood.bsky.social and collaborators!
MRC National Mouse Genetics Network@mrcmousenetwork.bsky.social · 6mo agoFresh insights reveal how cancer gene mutations drive tumour growth: Andrew Wood (lead of our Degron Cluster) has co-led a team that created a comprehensive map that shows how hundreds of possible mutations in a key cancer gene influence tumour growth nmgn.mrc.ukri.org/news/fresh-i...
Read more about a new map showing how hundreds of possible mutations in a key cancer gene influence tumour growth 👉 edin.ac/3NTaToX @andrewwood.bsky.social @roslininstitute.bsky.social @unileiden.bsky.social @koc-university.bsky.social @cmvm-edinburghuni.bsky.social
New map reveals cancer mutation effects | Institute of Genetics and Cancer | Institute of Genetics and Cancer
Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumour growth.
edin.ac
Today in @natgenet.nature.com, we report a saturation genome editing study that systematically dissects the degron of β-Catenin, which contains 5 of the 25 most frequently mutated regions of the human cancer genome, and >70 recurrent missense mutations. rdcu.be/e1Tvk
Our Best Models Working Group can offer advice on the use of a range of model systems. The next in our series highlighting our diverse expertise features Dr Andrew Wood, whose lab uses genome editing and targeted protein degradation to study genetic disease using cell lines, organoids, and mice.
Today's a good day to remember Rosalind Franklin, British chemist and X-ray crystallographer whose untimely death meant three men shared a Nobel prize for discovering the structure of DNA for which she'd done most of the work.
Folha de S.Paulo@folha.com · 9mo agoJames Dewey Watson (1928-2025): Morre James Watson, que ajudou a decifrar estrutura do DNA
On 14th November, we are once again holding our Network Science Day in York, which is an exciting opportunity for Network members and non-members to engage and develop new collaborations! The meeting is free to attend. Find out more and register by emailing us at Genetics_Network@har.mrc.ac.uk.
Look at this crazy thing! www.nature.com/articles/s41...
One mother for two species via obligate cross-species cloning in ants - Nature
In a case of obligate cross-species cloning, female ants of Messor ibericus need to clone males of Messor structor to obtain sperm for producing the worker caste, resulting in males from the same moth...
nature.com
Our manuscript characterising tissue-specific consequences of tagged protein fusions in CRISPR-engineered mice is now online @PLOSGenetics. journals.plos.org/plosgenetics.... Thanks again to all coauthors, reviewers and editors for a smooth publication process. Brief summary below.
Tissue-specific consequences of tag fusions on protein expression in transgenic mice
Author summary To better understand the function of specific proteins, researchers need ways to quantify their abundance, to visualise their movements, to understand what other molecules they interact...
journals.plos.org
Andrew Wood@andrewwood.bsky.social · last yr.Pleased to share our latest work and the first manuscript from the Degron Tagging Cluster in the MRC National Mouse Genetics Network. If you work with protein tags, particularly in tissue biology models, this should be of interest: www.biorxiv.org/content/10.1...
Oliver Smithies was born 100 years ago today. Best known for gene targeting in mice, for which he shared the 2007 Nobel, he also developed starch gel electrophoresis in the 1950s. I met him once and remember him being very gracious and thoughtful. #genetics #OTD www.nobelprize.org/prizes/medic...
Oliver Smithies – Facts - NobelPrize.orgOpen the search menuClose the search menuOpen the search menuClose the search menuSubmit a search termBack To Top
nobelprize.org
Pleased to share our latest work and the first manuscript from the Degron Tagging Cluster in the MRC National Mouse Genetics Network. If you work with protein tags, particularly in tissue biology models, this should be of interest: www.biorxiv.org/content/10.1...
biorxiv.org
New paper out in Genome Biology! 🎉 We lay out best-practice guidelines for releasing variant effect predictors, developed through the Atlas of Variant Effects Alliance @varianteffect.bsky.social Open, interpretable, and clinically useful VEPs are the goal. 📄 doi.org/10.1186/s130...
Guidelines for releasing a variant effect predictor - Genome Biology
Computational methods for assessing the likely impacts of mutations, known as variant effect predictors (VEPs), are widely used in the assessment and interpretation of human genetic variation, as well...
doi.org
The first bifunctional protein degrader to deliver Phase III data! It seems to work, but people were definitely expecting more:
A Bifunctional Degrader Reads Out in Phase 3
science.org
www.nature.com/articles/d41... #RIPTACs
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
Halda Therapeutics has started a clinical trial of its first-in-modality RIPTAC drug HLD-0915 in prostate cancer, to see if bifunctional drugs can provide tissue-specific activity.
nature.com
ICYMI: Commentary on "mechanism" in dev bio Ozpolat et al argue for diverse approaches to mechanism - from molecular to systems level journals.biologists.com/dev/article/...
A case for broadening our view of mechanism in developmental biology
ABSTRACT. Developmental biologists can perform studies that describe a phenomenon (descriptive work) and/or explain how the phenomenon works (mechanistic work). There is a prevalent perception that mo...
journals.biologists.com
Every once in a while we publish a paper that moves a whole field forward. I think that's the case for this one from the Bugaj lab, where they describe proteins for THERMOGENETIC control of cellular behavior. www.nature.com/articles/s41...
A temperature-inducible protein module for control of mammalian cell fate - Nature Methods
The Melt (Membrane localization using temperature) protein translocates to the plasma membrane upon temperature shift. Melt variants with a range of switching temperatures enable straightforward therm...
nature.com
🧪 Ready, set, degrade! So proud to share our work in the @jclinical-invest.bsky.social, establishing a versatile approach for creating transgenic dTAG mice to degrade oncoproteins. We showcase that KRAS G12V degradation triggers antitumor immunity in lung cancer. Link: www.jci.org/articles/vie...
🧪1/ 🚨New paper on ecDNAs from our lab! We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇 www.nature.com/articles/s41...
Engineered extrachromosomal oncogene amplifications promote tumorigenesis - Nature
Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in determining the role of oncogene a...
nature.com
Americans are now one-third less likely to die from cancer at the same ages as Americans in 1990
Essential reading for all that serve as reviewers. Please help your authors as if they were in your lab. Make your reviews constructive. Overly onerous reviews amount to blocking each others’ work. It slows progress and demoralizes junior investigators. Let’s elevate, not crush, #DevBio
James Briscoe@jamesbriscoe.bsky.social · 2y agoNew @dev-journal.bsky.social editorial We know we have high standards - but we're committed to making publishing with us constructive From clear revision guidance to limitations sections & transparent peer review, we're here to help you share your science journals.biologists.com/dev/article/...
New spinout Trogenix unveils its novel treatment platform that targets aggressive cancers, including brain cancer. IRR's Professor Steven Pollard is co-founder and Chief Scientific Officer #Cancer #RegenerativeMedicine #CRM regeneration-repair.ed.ac.uk/news/irr-new...
Seems that @biorxivpreprint.bsky.social ought to consider adding links to @bsky.app posts given the mass transfer of scientists from Twitter to @bsky.app that is taking place.
